DE69909782D1 - Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris - Google Patents

Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris

Info

Publication number
DE69909782D1
DE69909782D1 DE69909782T DE69909782T DE69909782D1 DE 69909782 D1 DE69909782 D1 DE 69909782D1 DE 69909782 T DE69909782 T DE 69909782T DE 69909782 T DE69909782 T DE 69909782T DE 69909782 D1 DE69909782 D1 DE 69909782D1
Authority
DE
Germany
Prior art keywords
lower alkyl
general formula
discloses
compounds
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69909782T
Other languages
English (en)
Inventor
Swastik Park Sankaranarayanan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrent Pharmaceuticals Ltd
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Application granted granted Critical
Publication of DE69909782D1 publication Critical patent/DE69909782D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69909782T 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris Expired - Lifetime DE69909782D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN935CA1998 IN188837B (de) 1998-05-22 1998-05-22
PCT/IB1999/000893 WO1999061018A1 (en) 1998-05-22 1999-05-17 Use of benzofuroxan derivatives in treating angina pectoris

Publications (1)

Publication Number Publication Date
DE69909782D1 true DE69909782D1 (de) 2003-08-28

Family

ID=11085434

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69909782T Expired - Lifetime DE69909782D1 (de) 1998-05-22 1999-05-17 Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
DE69918431T Expired - Fee Related DE69918431T2 (de) 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69918431T Expired - Fee Related DE69918431T2 (de) 1998-05-22 1999-05-17 Benzofuroxanderivate und ihre verwendung zur behandlung von angina pectoris

Country Status (16)

Country Link
US (2) US6248895B1 (de)
EP (2) EP1079829B1 (de)
JP (2) JP2002516275A (de)
CN (2) CN1301258A (de)
AT (2) ATE245419T1 (de)
AU (2) AU3623299A (de)
BR (2) BR9910628A (de)
CA (2) CA2333001A1 (de)
CZ (1) CZ20004072A3 (de)
DE (2) DE69909782D1 (de)
ES (1) ES2222029T3 (de)
HU (2) HUP0102057A3 (de)
IN (1) IN188837B (de)
PT (1) PT1080081E (de)
RU (2) RU2209065C2 (de)
WO (2) WO1999061430A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
AU2002366756A1 (en) * 2001-12-20 2003-07-09 Alangudi Sankaranarayanan Use of benzofuroxan derivatives as antiplatelet agents
AU2003226603A1 (en) 2002-04-19 2003-11-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
AU2003278565A1 (en) * 2002-10-25 2004-05-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US7093310B2 (en) * 2005-01-03 2006-08-22 Miranda Industries, Inc. Beddress
US8822509B2 (en) 2006-12-29 2014-09-02 The University Of Queensland Pain-relieving compositions and uses therefor
CN101270068B (zh) * 2008-04-23 2011-05-18 常州亚邦齐晖医药化工有限公司 一种2-硝基-4-丙硫基苯胺的制备方法
AU2009266408C1 (en) * 2008-07-02 2015-12-10 The University Of Queensland Pain-relieving compositions of furoxan NO donors and uses thereof
RU2515413C2 (ru) * 2012-07-05 2014-05-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Производные 1,2,5-оксадиазолов, обладающие анти-вич активностью, фармацевтическая композиция, способ ингибирования интегразы вич-1
US8945338B2 (en) 2013-03-15 2015-02-03 Henkel US IP LLC Anaerobic curable compositions
CN104592145B (zh) * 2015-01-15 2017-05-17 山东大学 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567728A (en) * 1968-07-05 1971-03-02 Pfizer Process for the preparation of phenazine di-n-oxides and related compounds
US4014893A (en) * 1973-05-11 1977-03-29 Imperial Chemical Industries Limited 3,4-Cycloalkano furoxans
US4185018A (en) * 1978-08-21 1980-01-22 Ciba-Geigy Corporation Process for producing benzofurazan-1-oxides
US4544400A (en) * 1982-02-22 1985-10-01 Zoecon Corporation Compositions
JPS6072874A (ja) * 1983-09-28 1985-04-24 Kazuhiro Imai ２，１，３−ベンゾオキサジアゾ−ルの新規誘導体
JPS6383078A (ja) * 1986-09-25 1988-04-13 Honsyu Kagaku Kogyo Kk ベンゾフラザン−１−オキシドの製造方法
US5272164A (en) 1988-12-27 1993-12-21 Kirin Beer Kabushiki Kaisha Carboximidamide derivatives
US5032604A (en) * 1989-12-08 1991-07-16 Merck & Co., Inc. Class III antiarrhythmic agents
DE4218977A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Annellierte 1,2,5-Oxadiazol-2-oxide
DE4220264A1 (de) 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
US6110935A (en) * 1997-02-13 2000-08-29 The Regents Of The University Of California Benzofurazan compounds for enhancing glutamatergic synaptic responses

Also Published As

Publication number Publication date
DE69918431T2 (de) 2005-07-14
RU2209065C2 (ru) 2003-07-27
IN188837B (de) 2002-11-09
CA2333001A1 (en) 1999-12-02
HUP0102057A3 (en) 2002-12-28
EP1079829B1 (de) 2003-07-23
JP3378239B2 (ja) 2003-02-17
CN1301258A (zh) 2001-06-27
EP1080081A1 (de) 2001-03-07
JP2002516275A (ja) 2002-06-04
ES2222029T3 (es) 2005-01-16
US6232331B1 (en) 2001-05-15
JP2002516317A (ja) 2002-06-04
DE69918431D1 (de) 2004-08-05
ATE245419T1 (de) 2003-08-15
EP1079829A1 (de) 2001-03-07
AU3623299A (en) 1999-12-13
CN1302205A (zh) 2001-07-04
BR9910628A (pt) 2001-01-30
WO1999061430A1 (en) 1999-12-02
HUP0101584A2 (hu) 2001-11-28
CZ20004072A3 (cs) 2001-08-15
ATE270279T1 (de) 2004-07-15
CA2332950A1 (en) 1999-12-02
PT1080081E (pt) 2004-10-29
EP1080081B1 (de) 2004-06-30
US6248895B1 (en) 2001-06-19
RU2222532C2 (ru) 2004-01-27
HUP0102057A2 (hu) 2001-11-28
BR9910637A (pt) 2001-02-06
WO1999061018A1 (en) 1999-12-02
HUP0101584A3 (en) 2002-12-28
AU3623399A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DE69909782D1 (de) Verwendung von benzofuroxanderivaten zur behandlung von angina pectoris
NO176840C (no) Analogifremgangsmåte for fremstilling av 2,9-disubstituerte-4H-pyrido[1,2-aÅpyrimidin-4-oner
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE170170T1 (de) Hydroximsäurederivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu deren herstellung
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
DE69906728D1 (de) Verwendung von 4-piperidinmethanolderivaten zur behandlung von neuralentwicklungsstörungen
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
ATE126432T1 (de) Verwendung von bisphenol-derivaten zur behandlung von diabetes mellitus.
DE3884878D1 (de) Uricosuretische Zusammensetzung.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
SE9700803D0 (sv) Farmaceutisk komposition för behandling av s k restless legs
ATE149352T1 (de) Thiadiazol-derivate zur behandlung von depressiven zuständen
HUP0002054A2 (hu) N-4-(nitro-metil-szulfonil)-fenil-alkánamid és -benzolszulfonamid-származékok, alkalmazásuk, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
HUP0100750A2 (hu) Új 6-szulfamoil-3-kinolilfoszfonsav származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyszerkészítmények
KR950017956A (ko) N-치환 아자비시클로헵탄 유도체, 그의 제조 방법 및 용도
RU94026275A (ru) Фармацевтические композиции для профилактики и/или лечения желудочно-кишечных заболеваний, включая язву

Legal Events

Date Code Title Description
8332 No legal effect for de